In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from ...

In July, Embecta, a manufacturer of disposable insulin pen needles and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from ...

Good day, and welcome to the Embecta Fourth Quarter of Fiscal Year ... which occurred in Q4 as well as the launch of a small-pack GLP-1 pen needle set in Germany, with the intent to address ...

the recent launch of our small-pack GLP-1 needles in Germany has gone well, and we are evaluating expanding into other markets,” said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta ...

Paleoindians at Wyoming's LaPrele mammoth site made needles from the bones of fur-bearers, likely to creat garments from the animals' furs to keep warm in a cool climate. A Wyoming archaeological ...

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles ...

After adding nearly 30% in the previous session following its better-than-expected Q4 results for FY24, Embecta (NASDAQ:EMBC) shares continued to trade higher as BTIG upgraded the medical device ...

Good day, and welcome to the Embecta fourth quarter of fiscal year 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now ...

BTIG upgraded Embecta (EMBC) to Buy from Neutral with a $26 price target Shares gained about 30% in Tuesday trading as investors rewarded management’s decision to discontinue the patch pump ...